Pre‐emptive (Neo‐adjuvant) Intravenous Chemotherapy for Invasive Bladder Cancer

British Journal of Urology

Volumn 61, Issue 1, 1988, Pages 1-8

  RAGHAVAN, D ^a  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BLADDER CANCER; CANCER CHEMOTHERAPY; CANCER INVASION; INTRAVENOUS DRUG ADMINISTRATION; NORMAL HUMAN; PRIORITY JOURNAL; REVIEW;

AGED; ANTINEOPLASTIC AGENTS; BLADDER NEOPLASMS; CARCINOMA, TRANSITIONAL CELL; CISPLATIN; CLINICAL TRIALS; COMBINED MODALITY THERAPY; HUMAN; INJECTIONS, INTRAVENOUS; MIDDLE AGE;

EID: 0023840951     PISSN: 00071331     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.1988.tb09152.x     Document Type: Review

References (43)

1. Treatment of T3 bladder cancer: controlled trial of pre‐operative radiotherapy and radical cystectomy versus radical radiotherapy. Second report and review (for the Clinical Trials Group, Institute of Urology)
2. Review of 150 post‐mortems of carcinoma of the urinary bladder
3. Current concepts in the management of patients with deeply invasive bladder cancer
4. Cis‐diamminedi‐chloro‐platinum (DDP) as initial treatment of invasive bladder cancer
5. Neo‐adjuvant chemotherapy in locally advanced bladder carcinoma
6. A mathematical model for relating the drug sensitivity of tumors to their spontaneous mutation rate
7. Treatment of invasive bladder cancer by local resection and high dose methotrexate
8. Transurethral resection and chemotherapy or radiotherapy for invasive bladder cancer
9. Cisplatin, methotrexate and vinblastine (CMV): an effective chemotherapy regimen for metastatic transitional cell carcinoma of the urinary tract. A Northern California Oncology Group Study
10. Pre‐operative irradiation with and without chemotherapy as adjunct to radical cystectomy
11. A randomised comparison of cisplatinum (C) versus cisplatinum and methotrexate (C + M) in advanced bladder cancer
12. Combination of chemotherapy and irradiation of non‐resectable bladder carcinoma
13. Long‐term intra‐arterial infusion chemotherapy with Adriamycin for advanced bladder cancer
14. Chemotherapy before radiotherapy for T3 bladder cancer. A pilot study
15. The hypoxic tumor cell: a target for selective cancer chemotherapy
16. Comparative activity and toxicity of cis‐diammine dichloroplatinum (DDP) and a combination of doxorubicin, cyclophosphamide, and DDP in disseminated transitional cell carcinoma of the urinary tract
17. Combined intravenous and intra‐arterial cyclophosphamide, doxorubicin, and cisplatin (CISCA) in the management of select patients with invasive urothelial tumors
18. The interaction of radiation and cis‐diamminedichlo‐roplatinum (II) in intestinal crypt cells
19. Intra‐arterial chemotherapy as an adjuvant to surgery in transitional cell carcinoma of the bladder
20. Methotrexate as salvage or adjunctive therapy for primary invasive carcinoma of the bladder
21. First‐line intravenous cisplatin for deeply invasive bladder cancer: update on 70 cases
22. First‐line intravenous cisplatinum for invasive clinically non‐metastatic bladder cancer
23. First‐line intravenous chemotherapy for invasive bladder cancer
24. Intravenous cis‐platinum for invasive and clinically non‐metastatic bladder cancer: safety and feasibility of a new approach
25. First‐line intravenous cisplatin in the treatment of invasive non‐metastatic bladder cancer
26. Initial intravenous cis‐platinum therapy: improved management for high risk bladder cancer?
27. Radiotherapy in the management of bladder cancer: results and innovations
28. Treatment of advanced bladder carcinoma with irradiation and concomitant 5‐fluorouracil infusion
29. Bladder cancer xenografts: a model of tumor cell heterogeneity
30. Neoadjuvant MVAC for transitional cell carcinoma of the urothelium
31. Intra‐arterial chemotherapy of infiltrative bladder carcinoma
32. Cisplatin and full dose irradiation for patients with invasive bladder carcinoma: a preliminary report of tolerance and local response
33. Neo‐adjuvant M‐VAC chemotherapy in invasive transitional cell carcinoma of the bladder: a pilot study
34. Current perspectives in the management of high grade invasive bladder cancer
35. A comparison of cisplatin and the combination of cisplatin and cyclophosphamide in advanced urothelial cancer
36. Cis‐diammine‐dichloroplatinum (II) in locally advanced and metastic urothelial cancer
37. Concurrent radiation and cisplatin in the treatment of advanced bladder cancer: a preliminary report
38. Preliminary results of M‐VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for transitional cell carcinoma of the urothelium
39. Combination chemotherapy (CISCA) for advanced urinary tract carcinoma: a preliminary report
40. Integrated irradiation and cystectomy for bladder cancer